Dyax Corp. and Novellus Biopharma AG Announce Partnership to Develop and Commercialize HAE Drug in Latin America

News   Feb 04, 2013

 
Dyax Corp. and Novellus Biopharma AG Announce Partnership to Develop and Commercialize HAE Drug in Latin America
 
 
 

RELATED ARTICLES

Quotient Clinical Signs Cocrystal Agreement with Nuformix

News

Partnership to evaluate cocrystal formulations using translational pharmaceutics.

READ MORE

Ingenza Advances inABLE® Biomanufacturing Technologies in Collaboration with Syngenta

News

Ingenza has reached a major technical milestone with Syngenta in their collaboration to develop efficient manufacturing technologies for innovative crop protection products.

READ MORE


 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE